↓ Skip to main content

Cochrane Database of Systematic Reviews

Quetiapine for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, April 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

policy
1 policy source
twitter
9 X users
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
100 Dimensions

Readers on

mendeley
194 Mendeley
Title
Quetiapine for schizophrenia
Published in
Cochrane database of systematic reviews, April 2004
DOI 10.1002/14651858.cd000967.pub2
Pubmed ID
Authors

Manit Srisurapanont, Benchalak Maneeton, Narong Maneeton, Sudheer Lankappa, Rahul Gandhi

Abstract

Quetiapine is an atypical antipsychotic with, theoretically, a low propensity for movement disorder adverse effects. It is used for the treatment of schizophrenia and other psychoses.

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 194 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 194 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 25 13%
Researcher 24 12%
Student > Ph. D. Student 17 9%
Student > Doctoral Student 15 8%
Student > Bachelor 15 8%
Other 37 19%
Unknown 61 31%
Readers by discipline Count As %
Medicine and Dentistry 50 26%
Psychology 24 12%
Pharmacology, Toxicology and Pharmaceutical Science 15 8%
Nursing and Health Professions 12 6%
Neuroscience 5 3%
Other 17 9%
Unknown 71 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 September 2020.
All research outputs
#3,577,420
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#6,116
of 11,499 outputs
Outputs of similar age
#6,152
of 62,526 outputs
Outputs of similar age from Cochrane database of systematic reviews
#10
of 34 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 62,526 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.